DBV Technologies share price logo

DBV Technologies

NASDAQ: DBVT

Small Cap

$19.50

-0.50

(-2.50%)

Live

as on

DBV Technologies Stock Performance

as on May 14, 2026 at 5:13 am IST

  • Day's High

    $19.50
    $19.88

    1.95%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.53
    $26.19
    downward going graph

    61.40%

    Downside

    34.28%

    Upside

    downward going graph

DBV Technologies share price movements today

Previous Close
$20.00
Open
$19.59
Volume
149.9K
Day's Low - High
$19.50 - $19.88
52 Week Low - High
$7.53 - $26.19

DBV Technologies Historical Returns

1 Month Return
-9.67 %
3 Month Return
-4.31 %
1 Year Return
+ 81.98 %
3 Year Return
+ 1.01 %
5 Year Return
-66.67 %

DBV Technologies Stock Fundamentals & Key Indicators

Check DBV Technologies market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

-0.4463

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-165.2M

Revenue (TTM)

5.7M

Profit Margin

0.00%

Return On Equity TTM

-158.89%

DBV Technologies vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of DBV Technologies with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
DBV Technologies image
DBV Technologies
BUY$1.2B-66.67%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B119.7%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B109.14%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for DBV Technologies Stock including INR - Dollar returns

The DBV Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

DBV Technologies investment value today

Current value as on today

₹1,99,137

Returns

₹99,137

(+99.14%)

Returns from DBV Technologies Stock

₹77,434 (+77.43%)

Dollar Impact

₹21,703 (+21.7%)

Analyst Recommendation on DBV Technologies Stock

Based on 8 analysts

BUY

75.00%

Buy

12.50%

Hold

12.50%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for DBV Technologies. Average target price of $40.99

DBV Technologies Share Price Target

Get share price movements and forecasts by analysts on DBV Technologies.

What analysts predicted

52.43%UPSIDE

Target Price

$40.99

Current Price

$19.5

Analyzed by

8 Analysts

Target

$40.99

DBV Technologies target price $40.99, a slight upside of 52.43% compared to current price of $19.5. According to 8 analysts rating.

Indian Investors' Interest in DBV Technologies Stock

Search interest for DBV Technologies Stock has increased by 41% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:41% versus previous 30 day period

DBV Technologies Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
9
1
1
1
-
0
-
-
-
-
Gross Profit
9
1
-4
1
-
0
-4
-4
-4
-
Operating Income
-11
-28
-34
-30
-23
-26
-43
-36
-45
-47
EBITDA
-8
-26
-30
-28
-22
-25
-38
-31
-43
-45
Interest Expense
22
-
-
0
-
0
0
-
-
-
Depreciation
-10
0
-1
0
0
0
0
0
0
0
Income Before Tax
11
-27
-34
-30
-23
-27
-43
-35
-44
-47
Income Tax Expense
0
0
-1
-
0
0
-1
-2
0
0
Net Income
-12
-29
-35
-33
-23
-27
-42
-33
-44
-47
Net Profit Margin
-126.04%
-1943.50%
-2849.70%
-2839.74%
0.00%
-5299.22%
0.00%
0.00%
0.00%
0.00%

DBV Technologies Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
8
13
14
16
13
6
5
17
2
-
Gross Profit
8
13
14
16
13
-4
-16
17
-6
-17
Operating Income
-122
-173
-190
-171
-158
-98
-96
-76
-120
-147
EBITDA
-126
-176
-206
-168
-124
-91
-76
-63
-110
-139
Interest Expense
0
3
0
0
0
0
0
-
0
-
Depreciation
-
2
2
5
10
8
13
8
0
3
Income Before Tax
-126
-177
-190
-171
159
-98
-96
-72
-117
-146
Income Tax Expense
1
0
0
0
0
0
0
0
-4
0
Net Income
-133
-209
-216
-191
-194
-110
-101
-79
-113
-146
Net Profit Margin
-1593.88%
-1538.29%
-1484.65%
-1169.51%
-1415.00%
-1713.54%
-2006.25%
-462.40%
-4428.22%
0.00%

DBV Technologies Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-27
-33
-30
-23
-23
-41
-33
-44
-47
Operating Cash Flow
-34
-35
-22
-12
-19
-33
-32
-35
-49
Investing Cash Flow
-2
0
0
-
0
0
0
0
0
Financing Cash Flow
0
0
0
0
0
116
0
159
88
Change in Cash
-39
-35
-19
-13
-19
90
-33
124
35

DBV Technologies Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-207
-227
-172
-159
-97
-96
-72
-113
-146
Operating Cash Flow
-160
-186
-148
-165
-108
-55
-79
-104
-121
Investing Cash Flow
-11
-11
-5
-2
0
0
0
0
-1
Financing Cash Flow
0
178
207
149
0
194
6
0
276
Change in Cash
-166
-20
52
3
-119
131
-67
-108
161

Global Institutional Holdings in DBV Technologies

Funds
Holdings
Boxer Capital Management, LLC
0%
Vivo Capital, LLC
4.16%
Redmile Group, LLC
0.93%
Barclays PLC
0.05%
Ikarian Capital, LLC
0.89%
See all

DBV Technologies News & Key Events

  • img

    Today's Timeline - 17 December

    Wed, 02:38 PM

    -

    DBV Technologies announces positive Phase 3 trial results for Viaskin Peanut patch, meeting primary endpoint for peanut allergies in children.

Insights on DBV Technologies

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DBVT has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 31.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -33.01M → -47.6M (in $), with an average decrease of 21.0% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 5 quarters, 8.87M → 511.0K (in $), with an average decrease of 40.4% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, DBVT stock has moved down by -9.7%

About DBV Technologies

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
OrganisationDBV Technologies
HeadquartersBâtiment IRO, Châtillon, France, 92320
IndustryBiotechnology
CEOMr. Daniel Tassé
E-voting on sharesClick here to vote

Key Management of DBV Technologies

Name

Title

Mr. Daniel Tassé

CEO & Director

Ms. Virginie Simone Jeanine Verrechia Boucinha M.B.A.

Chief Financial Officer

Dr. Kevin P. Malobisky M.S., Ph.D., R.A.C.

Chief Operations Officer

Mr. Pascal Wotling

Chief External Manufacturing & Supply Chain Officer

Dr. Pharis Mohideen M.D.

Chief Medical Officer

Mr. Jonathan Neely

VP & Head of Investor Relations

Ms. Michele F. Robertson

Chief Legal Officer

Mr. James Briggs

Chief Human Resources Officer

Mr. Kevin Trapp

Chief Commercial Officer

Alan Kerr

Senior VP & Head of Global Regulatory Affairs

FAQs

What is DBV Technologies share price today?

DBV Technologies share price today is $19.5 as on . DBV Technologies share today touched a day high of $19.88 and a low of $19.5.

What is the 52 week high and 52 week low for DBV Technologies share?

DBV Technologies share touched a 52 week high of $26.19 on and a 52 week low of $7.53 on . DBV Technologies stock price today i.e. is trending at $19.5,which is 25.53% down from its 52 week high and 159.09% up from its 52 week low.

What is DBV Technologies's market capitalisation today?

DBV Technologies market capitalisation is $0.00T as on .

How to invest in DBV Technologies Stock (DBVT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for DBV Technologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in DBV Technologies Shares that will get you 0.0769 shares as per DBV Technologies share price of $19.5 per share as on May 13, 2026 at 11:43 pm IST.

What is the minimum amount required to buy DBV Technologies Stock (DBVT) from India?

Indian investors can start investing in DBV Technologies (DBVT) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in DBV Technologies stock (as per the Rupee-Dollar exchange rate as on ). Based on DBV Technologies share’s latest price of $19.5 as on May 13, 2026 at 11:43 pm IST, you will get 0.5128 shares of DBV Technologies. Learn more about fractional shares .

What are the returns that DBV Technologies has given to Indian investors in the last 5 years?

DBV Technologies stock has given -66.67% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?